LakeShore Biopharma Receives Acquisition Proposal from Oceanpine Capital LakeShore Biopharma has received a preliminary non-binding proposal to be acquired for $0.86 per share, marking a 10.3% premium over recent prices.

LakeShore Biopharma Receives Acquisition Proposal from Oceanpine Capital #China #Beijing #LakeShore_Biopharma #Oceanpine_Capital #firm_acquisition